A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActive^TM) for COVID-19 Patients

Table 3

Screening/baseline demographic details and vital signs (mean ± SD).

Parameters	ImmuActive^TM (N = 50)	Placebo (N = 50)	value
Age (years)	39.04 ± 7.70	37.28 ± 7.40	0.159 (NS)
Height (cm)	167.32 ± 6.40	166.18 ± 6.30	0.785 (NS)
Weight (kg)	67.96 ± 6.25	70.08 ± 7.56	0.304 (NS)
BMI (kg/m^2)	24.32 ± 1.91	25.40 ± 2.14	0.064 (NS)
Systolic blood pressure (mmHg)	122.42 ± 7.54	123.30 ± 10.28	0.396 (NS)
Diastolic blood pressure (mmHg)	79.30 ± 7.72	80.82 ± 7.82	0.496 (NS)
Body temperature (°F)	98.43 ± 0.96	98.35 ± 0.72	0.678 (NS)
Pulse rate (beats/min)	90.56 ± 7.49	92.02 ± 7.32	0.474 (NS)
Oxygen saturation (SpO2) %	96.90 ± 0.99	97.06 ± 1.15	0.293 (NS)

NS, not significant.